Electronic Patient‐Reported Outcome Quality of Life Score in Japanese Patients With Pancreatic Cancer on Second‐Line Chemotherapy: A Multicenter Observational Study
Patients' QoL score assessment over time by ePRO revealed QoL score trends, which emphasized the importance of QoL management outside of hospital visits for each chemotherapy.
Authors
- Takeru Shiroiwa (ORCID: https://orcid.org/0000-0003-3055-9932)
- Masafumi Ikeda
- Masato Ozaka (ORCID: https://orcid.org/0000-0002-5666-1970)
- Chigusa Morizane
- Manabu Akazawa (ORCID: https://orcid.org/0000-0002-4112-6035)
- Akihiro Ohba (ORCID: https://orcid.org/0000-0002-9153-3798)
- Makoto Ueno (ORCID: https://orcid.org/0000-0003-4480-0029)
- Kenji Ikezawa (ORCID: https://orcid.org/0000-0001-7517-8960)
- Takeshi Terashima (ORCID: https://orcid.org/0000-0002-1052-0101)
- Hiroto Narimatsu
- Naohiro Okano (ORCID: https://orcid.org/0000-0002-4098-5217)
- Takuji Okusaka (ORCID: https://orcid.org/0000-0003-1729-807X)
- Yuki Takumoto (ORCID: https://orcid.org/0000-0001-9191-3494)
- J. Furuse
Institutions
- Kyorin University (JP)
- Meiji Pharmaceutical University (JP)
- Kanagawa Prefectural Hospital Organization (JP)
- National Institute of Public Health (JP)
- Kanazawa University Hospital (JP)
- The Cancer Institute Hospital (JP)
- National Cancer Center Hospital East (JP)
- Osaka International Cancer Institute (JP)
- Kanagawa Cancer Center
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1002/cam4.71161
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pitt Hopkins Research Foundation